Viewing Study NCT03414034


Ignite Creation Date: 2025-12-25 @ 2:27 AM
Ignite Modification Date: 2025-12-26 @ 1:01 AM
Study NCT ID: NCT03414034
Status: COMPLETED
Last Update Posted: 2024-11-07
First Post: 2018-01-22
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Onvansertib in Combination With Abiraterone and Prednisone in Adult Patients With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Cardiff Oncology
Organization: